Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies
Journal of Hematology · 2022-12 · 11 (6) · 197-209
DOI: 10.14740/jh1042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Hematology, 2022-12. Verfasst von Zoe McKinnell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, George Washington University Hospital, Washington, DC, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and Oncology, George Washington University Hospital, Washington, DC, USA.
ORCID-Profile: Zoe McKinnell
Zitieren
APA
McKinnell, Z., Karel, D., Tuerff, D., Sh Abrahim, M., & Nassereddine, S. (2022). Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies. Journal of Hematology, 11(6), 197-209. https://doi.org/10.14740/jh1042
Vancouver
McKinnell Z, Karel D, Tuerff D, Sh Abrahim M, Nassereddine S. Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies. Journal of Hematology. 2022;11(6):197-209. doi:10.14740/jh1042
BibTeX
@article{McKinnell2022,
author = {McKinnell, Zoe and Karel, Daniel and Tuerff, Daniel and Sh Abrahim, Marwa and Nassereddine, Samah},
title = {Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies},
journal = {Journal of Hematology},
year = {2022},
volume = {11},
number = {6},
pages = {197--209},
doi = {10.14740/jh1042}
}
EUVIMED